mianserin has been researched along with Cancer of Esophagus in 2 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hannon, B | 1 |
Fitzgerald, P | 1 |
Murphy, M | 1 |
Masuzawa, M | 1 |
Taguchi, H | 1 |
Sugimoto, T | 1 |
Kojima, H | 1 |
Matsumoto, S | 1 |
Kojima, K | 1 |
Shingu, K | 1 |
2 other studies available for mianserin and Cancer of Esophagus
Article | Year |
---|---|
Treatment of depression as part of end-of-life care.
Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Carcinoma, Squamou | 2008 |
[Case of successful management with mirtazapine for prolonged pain after esophagectomy].
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Esophageal Neoplasms; Esophagectomy; | 2012 |